|Articles|January 11, 2019

Update on the ELIANA trial (VIDEO)

Author(s)Bobby Lazzara, MD

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

PCOS to PMOS: A long-awaited change

Diagnosing PMOS in adolescents: Criteria, ultrasound limits, and red flags

From primary care to specialist: Managing PMOS and insulin resistance

AAP expands RSV immunization recommendations for high-risk children

Top 5 pediatric health headlines you missed in August 2026